I-Corps: Translation potential of a microfluidic device to improve gene editing of therape — NSF Award to University of California
The broader impact of this I-Corps project is the development of a biotechnology tool to increase gene editing efficiency and accelerate the development of cell therapies. Gene editing technology, a method for making specific changes to the DNA of a cell, is used to turn human cells into therapeutic cells. The method m
| Award title | I-Corps: Translation potential of a microfluidic device to improve gene editing of therape |
|---|---|
| Award ID | 2436358 |
| Awardee | University of California-Los Angeles |
| City | LOS ANGELES |
| State | CA |
| Amount obligated | $50,000 |
| Principal investigator | Song Li |
| Program | I-Corps |
| Start date | 09/01/2024 |
| Abstract | The broader impact of this I-Corps project is the development of a biotechnology tool to increase gene editing efficiency and accelerate the development of cell therapies. Gene editing technology, a method for making specific changes to the DNA of a cell, is used to turn human cells into therapeutic cells. The method may be used as a potential treatment and cure for many diseases including cancer. Currently, however, this application is limited by the low efficiency of gene editing, which result |
| Source | NSF Awards |
$799/mo
Try NSFGrants →